- Home
- VIRT vs XENE Comparison
VIRT vs XENE Comparison
Compare VIRT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VIRT | XENE |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.2B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VIRT | XENE |
|---|---|---|
| Price | $50.51 | $58.49 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | $44.14 | ★ $67.17 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | ★ 72.73 | N/A |
| EPS | ★ 5.13 | N/A |
| Revenue | ★ $3,632,118,000.00 | $311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.81 | $2,436.26 |
| P/E Ratio | $9.87 | ★ N/A |
| Revenue Growth | ★ 26.25 | N/A |
| 52 Week Low | $31.55 | $28.19 |
| 52 Week High | $52.21 | $62.91 |
Technical Indicators
Market Signals| Indicator | VIRT | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 73.11 | 61.73 |
| Support Level | $41.55 | $39.93 |
| Resistance Level | N/A | $59.44 |
| Average True Range (ATR) | 1.47 | 1.83 |
| MACD | 0.42 | -0.22 |
| Stochastic Oscillator | 82.53 | 72.68 |
Price Performance
Historical ComparisonAbout VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.